What Is Hpv ( Human Papilloma Virus )? Hpv?

HPV is by far the most common sexually transmitted infection in the United States. Per the Centers for Disease Control and Prevention (CDC), 50 percent of all sexually active men and women will get it at some point in their lives, and 20 million already have it. A vaccine is available that prevents 70% of cervical cancers that arise from sexual intercourse. The human papillomavirus is unknowingly common and is diagnosed in 10,000 women a year, causing 4,000 deaths per year (“HPV Question and Answers”). If we take the responsibility to vaccinate young girls and boys, to be safe, we can eliminate many unnecessary deaths. This vaccine is a great discovery that should be put to good use, the HPV vaccine should be mandated in young teens everywhere.

HPV vaccination is the most common used method for preventing cervical cancer in young girls ranging from age nine to eleven years old. The overall perception of the vaccine is positive by the public because of its wide use and support by state laws, school systems and medical associations. According to the American Pediatric Association the vaccine has an excellent safety record. (Nirvi,1) A reasonable amount of parents still feel skeptical about mandatory HPV vaccination on their kids and lack great knowledge regarding the vaccine’s effectiveness.

The Human Papillomavirus (HPV) is the most common sexually transmitted infection (STI). There are over 100 types of HPV, but only 40 types affect the genital area and can cause genital warts and cervical cancer in women (“Human Papillomavirus (HPV) Vaccine”). In 2011 in the United States, 12,109 women were diagnosed with cervical cancer. Of those, 4,092 women died (“Cervical Cancer Statistics”). HPV is not only contracted from sexual intercourse, but also from skin to skin contact, including oral sex. The STI affects males and females involved in both homosexual and heterosexual sexual activities. Over 70 percent of sexually active individuals contract and carry HPV before the age of 80. In order to combat HPV two different brands of HPV vaccination – Gardasil and Cervarix – were created. Both include a vaccination plan of three shots over the course of six months. Gardasil was created by Merck & Co., and was licensed by the FDA in June 2006. The vaccine protects against HPV types 16 and 18, which lead to cervical cancer, as well as types 6 and 11, which cause 90% of genital warts. The FDA later approved Cervarix, created by GlaxoSmithKline, in 2009, which only protects against HPV types 16 and 18 (“Human Papillomavirus (HPV) Vaccine”). Originally, Gardasil was only approved for females, but three years after the release, the vaccine was approved

HPV stands for the human palliloma virus. It is estimated that there are around 100 different types of HPV. The HPV virus can cause lesions to develop on the soft palate, tonsils and tongue. It can also increase the risk of certain forms of cancer, including oral cancer and cervical cancer.

The disease specifically affects those in poverty and results in higher rates of cancer in black and Hispanic women. (Source) Some states are starting to require female students in public schools to receive vaccination for HPV by the sixth grade. (Source) When public schools become advocates for a vaccination, it tends to be a big ordeal and starts to catch on. This virus is showing just how complex and controversial making a vaccine mandatory can be. Parents are starting fear that making it a requirement is implicitly condoning sex before marriage or sex with multiple partners. (source)Media is starting to show that it plays a big part as well because during the CNN-Tea party Republican presidential debate on September 13, 2011, that mandate came under fire when candidate Michele Bachman claimed that the vaccine was dangerous

HPV is the single biggest cause of cervical cancer and oropharyngeal cancers, according to the CDC. Between 2008 and 2012, almost 39,000 U.S. citizens were diagnosed with HPV-related cancer every year. Fifty-nine percent of them women and 41 percent men, researchers report. But while Pap smears and HPV tests have reduced rates of cervical cancer in woman, rates of oral cancer are growing in men.

The HPV vaccine is cancer prevention. Over thousands of cases of HPV cancers are detected every year in men and women. The HPV vaccination is important because it can prevent these cancers. The United States Food and Drug Administration approved this vaccine and it is one hundred percent safe. This vaccine is preventive care for the second leading cancer in women. It has been proven to be one hundred percent effective in prevention of cervical cancer, but the vaccine must be given to children between the age of 11 -17 before they become sexually active. After the age seventeen with young women most become sexually active and receive their first pap smear from their gynecologist, receiving the vaccine at this point is not as effective in prevention of cancers. Another benefit of receiving the vaccine during adolescent, is it supports people who may not have the medical knowledge or access to regular medical services.

Castle and colleagues did a study to determine the appropriate age for HPV vaccination. They stated that in the United States cervical cancer screening program has achieved 75% reduction in incidence of the cervical cancer and HPV vaccine will only reduce additional cancer cases and other HPV related sequelae such as carcinoma intraepithelial neoplasia (CIN) 2 and CIN 3. These are the precancerous lesions. The vaccine will be effective only for those who are never exposed to HPV infection. It will have no use for those who are already infected or exposed.. According to the study the median age for CIN 2/3 lesion was between the ages 25 to 30. If the time since acquiring infection and development of CIN 2/3 is on average 5 to 10 years, HPV vaccine will prevent CIN 2/3 only if given to women before age of 26 years with best results if given before 18 years of age (Castle, et

In the state of Florida, between 1981 and 2009, there was a higher incidence of cervical, vaginal, and penile cancer in the black population, a higher incidence of anal cancer in the Hispanic population, and a

Thesis statement: Healthcare providers should educate the parents of 11-12 year old boys and girls about human papillomavirus (HPV) infection and the HPV vaccine because HPV infection is prevalent and the chance of an adolescent being infected is high, persistent infection with the high-risk types 16 and 18 can cause serious health problems, and in order to assure effectiveness, the vaccine must be administered prior to contact with the virus.

HPV vaccinations have been an ongoing debate; whether the vaccine is worth being administered to young girls is the fundamental question and if so at what cost. The primary reason I selected this topic is that HPV is a common virus complicated and often misunderstood infection; nearly 80 million people, about one in four are currently infected in the United States.

Studies show that the amount of responders was about 100% for both of the vaccines while the magnitude of the responses in CervarixⓇ were usually higher than those in GardasilⓇ. It has been shown in studies protection can last at least 6.4 years for CervarixⓇ and 5 years for GardasilⓇ.5 The purpose of this review is to identify the efficacy and potential risk of HPV vaccines in prevention of Human Papillomavirus 16 and 18 in young girls. We will compare vaccines Gardasil and

Currently, cervical cancer is highly preventable. Nine out of ten women survive cervical cancer when it is caught and treated early (Texas Cancer). While annual pap smear is an important tool to detect cervical cancer, HPV vaccination in teenagers has been shown to decrease the rates of cervical cancer (Texas Cancer). As the current rate of HPV vaccination remains low, there is pressing need for an innovative solution to increase HPV vaccination among teenagers, especially those in high-risk groups such as Hispanics and African Americans.

The Human Papillomavirus (HPV) is a common sexually transmitted disease that infects the ano-genital tract of both males and females (Rubin, Kuttab, Rihani, & Reutzel, 2012, p. 1145). “A substantial burden of cancers and anogenital warts are attributable to HPV in the United States: in 2009, an estimated 34,788 new HPV-associated cancers and approximately 355,000 new cases of anogenital warts were associated with HPV infection” (CDC, 2015). The Gardasil quadrivalent vaccine was created to prevent the transmission of HPV. This vaccination is usually administered to adolescents between 11-12 years old and is a three dose series given over the course of six months. As a result of the extended vaccine period many patients are not completing the

The Human papillomavirus (HPV) is the virus responsible for cervical cancer. It is one the most common viral sexually transmitted infections. A vaccine was approved in 2006 that is effective in preventing the types of HPV responsible for 70% of cervical cancers and 90% of genital warts. Proposals for routine and mandatory HPV vaccination of girls have become sources of controversy for parents of school-aged youth, legislators, members of the medical community, and the public at large (Cooper et al. 2010).